Immune checkpoint inhibitors (ICIs), such as Programmed cell death receptor 1 (PD-1)/Programmed cell death ligand 1 (PD-L1) monoclonal antibody, are the most recent breakthrough in the treatment of cancer. Here, CD274 is linked to cancer.